At the recent American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting, researchers reported that treatment with benralizumab (Fasenra) was noninferior to mepolizumab (Nucala) for ...
Japanese partner Kissei Pharmaceutical Co., Ltd. said it has started information-sharing activities in Japan, urging ...
Please provide your email address to receive an email when new articles are posted on . Systemic corticosteroid use decreased with mepolizumab treatment. Mean daily oral corticosteroid use fell by 18% ...
LIVERPOOL -- Mortality remains high in granulomatosis with polyangiitis (GPA), but the causes of death tend to change over time, a researcher reported here. During the first year after diagnosis of ...
Granulomatosis with polyangiitis (GPA), previously known as Wegener’s granulomatosis, is a rare and life-threatening disorder that restricts the blood flow to several organs, including the lungs, ...
Granulomatosis with polyangiitis (GPA) is a rare condition where the blood vessels become inflamed GRANULOMATOSIS with polyangiitis is a serious condition that can have life-threatening consequences ...
The FDA has approved an expanded indication of AstraZeneca’s benralizumab (Fasenra) in the US for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA), a rare, ...
Please provide your email address to receive an email when new articles are posted on . Safety and tolerability were consistent with benralizumab’s known profile. Benralizumab is currently approved as ...
Patients with granulomatosis with polyangiitis (GPA) who scored high on a sinonasal symptom test are nearly three times as likely to relapse, according to a new study. These patients reported higher ...
Introduction: Granulomatosis with polyangiitis (GPA) is an autoimmune disease leading to necrotizing lesions in the affected tissues. Computed tomography (CT) of paranasal sinuses reveals multiple ...
A patient with MPA may suffer general symptoms or symptoms localized to the kidney, lungs, digestive tract, nerves, skin or heart. The patient may show initial symptoms of fever, muscle pains and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results